Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

AI-supported mammography screening significantly increases breast cancer detection rates while maintaining comparable recall ...

An observational, multicenter, real-world study conducted at 12 screening sites in Germany has reported a 17.6% higher cancer ...

Yale researchers are sifting through a mosaic of cells in a living animal—both normal cells and mutated cells—to better ...

The new test has demonstrated an initial 94% sensitivity rate in tumour detection and the test is delivered in under 20 ...

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...